Arora, MD, S., Setnik, PhD, B., Drass, MD, M., Hudson, MD, J. D., Clemmer, MS, R., Meisner, PharmD, P., Pixton, MS, G. C., Goli, MD, V., & Sommerville, MD, K. W. (2014). A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain. Journal of Opioid Management, 10(6), 423–436. https://doi.org/10.5055/jom.2014.0239